Clinical and prognostic features of plasmacytomas: A multicenter study of Turkish Oncology Group‐Sarcoma Working Party
- 9 June 2008
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 83 (9) , 702-707
Abstract
To identify the outcomes of prognostic factors of solitary plasmacytoma mainly treated with local radiotherapy (RT). The data were collected from 80 patients with solitary plasmacytoma (SP). Forty patients (50.0%) received radiotherapy (RT) alone while 38 of them (47.5%) were treated with surgery (S) and RT. The median radiation dose was 46 Gy (range 30–64). The median follow up was 2.41 years (range 0.33–12.33). Ten‐year overall survival (OS) and local relapse‐free survival (LRFS) were 73% and 94%, respectively. The median progression‐free survival (PFS) and multiple myeloma‐free survival (MMFS) were 3.5 years and 4.8 years, respectively. On multivariate analyses, the favorable factors were radiotherapy dose of ≥50 Gy and RT + S for PFS and younger age for MMFS. For the patients with medullary plasmacytoma, the favorable factor was younger age for MMFS. RT at ≥50 Gy and RT + S may be favorable prognostic factors on PFS. Younger patients, especially with head‐neck lesion and without pre‐RT macroscopic tumor, seem to have the best outcome when treated with RT ± S. Progression to MM remains as the main problem especially for older patients. Am. J. Hematol., 2008.Keywords
This publication has 36 references indexed in Scilit:
- Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapyCancer, 2006
- Radiotherapy in the management of solitary extramedullary plasmacytomaInternal Medicine Journal, 2005
- Solitary Bone and Extramedullary PlasmacytomaHematology-American Society Hematology Education Program, 2005
- Definitive radiotherapy for extramedullary plasmacytomas of the head and neckBritish Journal of Radiology, 2003
- Prognostic value of angiogenesis in solitary bone plasmacytomaBlood, 2003
- Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Among numerous DNA copy number changes, losses of chromosome 13 are highly recurrent in plasmacytomaGenes, Chromosomes and Cancer, 1999
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- THE NATURAL HISTORY OF EXTRAMEDULLARY PLASMACYTOMA AND ITS RELATION TO SOLITARY MYELOMA OF BONE AND MYELOMATOSISMedicine, 1976
- 352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence Data1973